Cancer Immunotherapy by Delivering Class II MHC Antigens Using a VLP-Replicon
Technology
E-050-2014
Patent ID
E-050-2014-0-HK-10
Country
HK
Application Type
CN
Patent Status
Abandoned
Patent Number
Publication Number
HK1231921A
Application Number
17105504.9
IC
NCI
Date Filed
Date Issued
Patent PDF